Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DEERFIELD, Ill.--(BUSINESS WIRE)--As a leading healthcare company, Walgreens announced today it has administered more than 29 million COVID-19 vaccinations across the U.S., as demand has increased more than 30 percent in some key areas and testing has more than doubled. It also now requires all U.S. team members to wear face covers, and everyone at support offices to be vaccinated (or enroll in a testing program). “As always, our top priority is ensuring the health and safety of our team member

Walgreens Surpasses 29 Million COVID-19 Vaccinations Administered, Implements New Policies to Continue to Lead Fight Against Pandemic

AbbVie

Gilead Sciences

GlaxoSmithKline

Pfizer

The healthcare sector is chock-full of safe, sturdy income plays. But these five top-rated high-yield dividend stocks really stand out in the crowd.

5 High-Yield Dividend Stocks for Healthy Income

Despite recent volatility, the major benchmarks wrapped up July with big monthly wins.

Stay Away from This Blue-Chip Stock in August

There are several reasons to own Walgreens Boots Alliance like the high dividend yield or the solid last quarterly results. But the major reason to own Walgreens Boots Alliance is simply the fact that the stock is deeply undervalued - even when calculating with cautious assumptions.

4 Reasons Why I Bought Walgreens Boots Alliance

Fortis

Coca-Cola

These companies have all increased their dividend payments for more than 45 years in a row.

Don't Work During Retirement -- Collect Money From These 3 Dividend Aristocrats Instead

LONDON and SAN FRANCISCO, Aug. 3, 2021 /PRNewswire/ -- Lemonaid Health, a San Francisco-based online healthcare company, is expanding internationally with the launch of its services in the United Kingdom in partnership with Boots UK. Boots is the U.K.'s leading pharmacy-led health and beauty retailer and is part of the WBA (Walgreens Boots Alliance) group.

Lemonaid Health Expands Internationally with U.K. Launch in Partnership with Drugstore Chain Boots

WBA is a storied retail pharmacy business that boasts a 120-year history and is an accomplished dividend growth stock.

Walgreens Boots Alliance: Diagnosing The Risks

Walgreens Boots Alliance And Buffett's 10x Pretax Rule

Kimberly-Clark

NEENAH, Wis., Aug. 2, 2021 /PRNewswire/ -- For the fifth consecutive year, Huggies®  and Walgreens are coming together in an effort to inspire local communities to help ensure families in need have access to clean diapers.

Huggies® And Walgreens® Rally Support For Families Struggling With Diaper Need

Walmart

Incumbent banks will have to innovate their digital and mobile strategies to compete with two of the country's biggest retailers. Retail banking has changed dramatically over the past several years, with the rise of digital banking and tech-forward neobanks like Dave and Chime, which pushed incumbent financial institutions to develop their own mobile-first offerings.

How Walgreens and Walmart's new banking ventures will shake up finance

Earlier this month, pharmacy chain Walgreens Boots Alliance, Inc. (NASDAQ:WBA) declared a quarterly dividend of 47.75 cents per share, an increase of 2.1%.

This Dividend Stock is Just What the Doctor Ordered

Bed Bath & Beyond

Disney

Enterprise Products Partners

Fiverr

IZEA

Lockheed Martin

OncoCyte

Osisko Gold Royalties

After the end of the second quarter, let's take a look at where things stand in the InvestorPlace Best Stocks for 2021 contest. The post 10 Best Stocks for 2021: Where Do Things Stand Halfway Through the Year?

10 Best Stocks for 2021: Where Do Things Stand Halfway Through the Year?

Kinder Morgan

Annaly Capital

Philip Morris

These rock-solid income stocks pay yields ranging from 4.1% to as high as 10.2%.

5 High-Yield Dividend Stocks to Buy Right Now That'll Help You Crush Inflation

Aetna

CVS Health

It all depends on whether this is just a first step.

What Will an Unexpected Revenue Boost Mean for This Leading Pharmacy Stock's Bottom Line?

DEERFIELD, Ill. & CHICAGO--(BUSINESS WIRE)--Walgreens and VillageMD are opening new Village Medical at Walgreens practices in Northern Indiana this year.

Walgreens and VillageMD Expand to Northern Indiana, Opening New Full-Service Primary Care Practices This Year

If this new approach to medical care takes hold, the local pharmacy on the corner could become your go-to healthcare facility.

This Pharmacy Giant Wants to Be Your Next Great Buy

Walgreens Boots Alliance Inc. ( WBA , Financial) is a leading pharmacy retailer in the U.S. that has benefited from the rollout of Covid-19 vaccinations. The company recently started providing vaccines to patients in the U.K. and has seen a visible increase in Ebitda margins over the past few quarters.

Walgreens Boots Alliance: An Undervalued Pharmacy Play

Ally Financial

Bank of New York Mellon

Cummins

Duke Energy

Goldman Sachs

Marsh & McLennan

Morgan Stanley

National Retail Properties

PPG Industries

Ryder System

State Street

This weekly article series covers dividend changes. A summary table provides relevant data and key statistics of dividend increases.

Dividend Increases: July 10-16, 2021

Realty Income Corp

Exxon Mobil

We have covered the Dividend Aristocrats stocks for years here at 24/7 Wall St. So it was kind of a seismic shock back in the spring when AT&T, a long-time charter member of the list, announced it would be cutting its cherished dividend.

5 Highest Yielding Dividend Aristocrat Stocks to Buy Now as Interest Rates Continue to Plunge

Apple

Abbott Labs

Blackrock Inc

Carrier Global

Colgate-Palmolive

iShares Core S&P 500 ETF

Johnson & Johnson

Lowe's

Medtronic

Microsoft

NIKE

Otis Worldwide

PepsiCo

QUALCOMM

Raytheon Technologies

Texas Instruments

Vanguard Dividend Appreciation ETF

Vanguard Short-Term Inflation-Protected Securities ETF

U.S. stocks moved to new all-time highs in the first half of 2021 as we eye the other side of the pandemic.

Our U.S. Stock Portfolio, First Half Of 2021 Review

Walgreens reported great earnings, but the stock sold off because investors feared a slowing in the vaccination rate. However, global vaccination should lead to economic recovery and a return to normality positively affecting Walgreens.

Walgreens Boots Alliance: Buy On The Weakness

Vanguard Real Estate ETF

YUM! Brands

I have invested in both REITs and rental properties, and think that REITs are far better investments in most cases. There are clear fundamental reasons why REITs are more rewarding in the long run.

Why REITs Are Far Better Investments Than Rental Properties

News for Walgreens Stock (WBA)